The estimated Net Worth of Paul Kwon is at least $108 Thousand dollars as of 11 December 2019. Paul Kwon owns over 80,300 units of Menlo Therapeutics stock worth over $108,405 and over the last 7 years Paul sold MNLO stock worth over $0.
Paul has made over 1 trades of the Menlo Therapeutics stock since 2019, according to the Form 4 filled with the SEC. Most recently Paul exercised 80,300 units of MNLO stock worth $108,405 on 11 December 2019.
The largest trade Paul's ever made was exercising 80,300 units of Menlo Therapeutics stock on 11 December 2019 worth over $108,405. On average, Paul trades about 20,075 units every 0 days since 2018. As of 11 December 2019 Paul still owns at least 80,300 units of Menlo Therapeutics stock.
You can see the complete history of Paul Kwon stock trades at the bottom of the page.
Paul's mailing address filed with the SEC is 200 Cardinal Way 2ND FLOOR, Redwood City, CA 94063, USA.
Over the last 7 years, insiders at Menlo Therapeutics have traded over $3,825,000 worth of Menlo Therapeutics stock and bought 3,655,938 units worth $21,205,011 . The most active insiders traders include Advisors Llcperceptive Life..., Llc Fmr, and Albert Cha. On average, Menlo Therapeutics executives and independent directors trade stock every 85 days with the average trade being worth of $572,944. The most recent stock trade was executed by Sharon Barbari on 20 August 2020, trading 75,000 units of MNLO stock currently worth $111,000.
Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Redwood City, CA.
Menlo Therapeutics executives and other stock owners filed with the SEC include: